PROCEPT BioRobotics Corporation
PRCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.71 | 1.84 | -1.13 | 4.60 |
| FCF Yield | -0.48% | -0.56% | -0.59% | -0.77% |
| EV / EBITDA | -93.97 | -173.75 | -132.46 | -248.36 |
| Quality | ||||
| ROIC | -5.04% | -4.77% | -5.82% | -4.07% |
| Gross Margin | 64.81% | 65.35% | 63.85% | 64.00% |
| Cash Conversion Ratio | 0.31 | 0.77 | 0.69 | 1.72 |
| Growth | ||||
| Revenue 3-Year CAGR | 37.10% | 39.34% | 42.98% | 44.11% |
| Free Cash Flow Growth | 46.75% | 5.16% | 43.94% | -76.23% |
| Safety | ||||
| Net Debt / EBITDA | 11.41 | 13.07 | 10.47 | 15.42 |
| Interest Coverage | 5.20 | -24.79 | -31.29 | -20.34 |
| Efficiency | ||||
| Inventory Turnover | 0.44 | 0.41 | 0.40 | 0.44 |
| Cash Conversion Cycle | 261.92 | 273.10 | 274.15 | 279.16 |